COMPANY INSIGHT

Sponsored by uintent 

We are User Experience and Human Factors experts

We have been applying HF/UE to medical device development longer than the FDA has been regulating it!

W

e are working as Human Factors and User Experience Consultants since 2000. We support our clients in developing safe and effective medical devices according to ISO 62366, FDA guidance and the EU Medical Device Regulation (MDR).



What we do

PLANNING & EXPLORATION

Are you about to get started and want to know more about your customers and what really moves them? Make sure you have all pieces in place by doing explorative research and fully understand your users needs and goals.

MEASURE & VALIDATE

If you want to measure your success or are under regulatory requirements, our validated measurement approaches are designed exactly for you.

DESIGN & ITERATE

Do you want to create a new and innovative service from scratch? Have you already built prototypes and just want to kink out usability flaws? Enter the cycle of ideation, design and testing to iteratively move from your first idea to a test-proven product!

MANAGEMENT & STRATEGY

Lift UX to the next level and systematically integrate it into your development process using our tools and experience.

About us

Our team includes industry pioneers with more than 20 years of experience in UX as well as young professionals from the fields of research and design. We have worked in large organizations as well as in start-ups and are happy to share our experience with you!

Our additional motivation kick: uintent is employee-owned. Researchers and designers are also our decision makers!


Your benefits:

Agility | No overhead | Flexibility | Professionalism | Creativity

We are uintent

uintent has offices in Hamburg, Basel and Munich. We operate in other German cities as needed.


We have sibling companies in the USA, Japan and China and mutually own each other.


These have a similar philosophy and organization and are closely linked to us - in these markets we operate as one company.

Our commitment to quality is part of our DNA

HF/UE best practices and industry standards are part of our DNA. Our research is conducted according to the guidelines found in IEC 62366-1, TR 62366-2, FDA guidance on applying HF/UE to medical device development, AAMI HE75, and other standards wherever appropriate.

We don’t just adhere to best practices; we work with other industry thought leaders to define them through our corporate memberships with AAMI and other organizations.

Contact information

uintent

Web: www.uintent.com
Email: hello@uintent.com

Go to article: Home | High-Tech Mental Health TreatmentsGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: PSN Labs Go to article: AccumoldGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: uintent Company InsightGo to article: uintentGo to article: Apple RubberGo to article: Custom Wire Company Insight Go to article: Custom WireGo to article: CommentGo to article: Hearing implants market to reach $2.1bn by 2028, post-Covid-19Go to article: Recent hacks highlight importance of strong cybersecurityGo to article: Disposable endoscopes set to disrupt the reusable endoscopes marketGo to article: Will Covid-19 tests with EUA need to seek FDA approval once pandemic passes?Go to article: Covid-19 had a negative impact on general surgery device markets in 2020Go to article: Desert Platforms Company Insight Go to article: Desert PlatformsGo to article: CombinosticsGo to article: Duke Empirical Company Insight Go to article: Duke EmpiricalGo to article: In DepthGo to article: How can AI transform pneumonia diagnosis?Go to article: Using virtual reality to overcome anxious social avoidanceGo to article: Omar Ahmad: medtech’s quest for post-Covid success in 2021Go to article: NightWare vs nightmares: the sleep tech app helping break PTSD patternsGo to article: Just a swipe away: how the NHS plans to offer health records on iPhoneGo to article: Diagnostic imaging: assessing the testicular cancer riskGo to article: Do AI disease prediction models underestimate risk?Go to article: Will 2021 be just as challenging as 2020 for medtech notified bodies?Go to article: HirLan Company InsightGo to article: HirLanGo to article: Ergonomics FactoryGo to article: FISBAGo to article: In DataGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issueGo to article: AxetrisGo to article: Smiths InterconnectGo to article: mdi ConsultantsGo to article: Omnica